Search research articles
Contact Us
Filters
Showing results (151-160 of 161) with videos related to
Page
of 17
Sort By:
Cancer Immunology Research
|
September 4, 2025
Liver metastases license neutrophils through IL-1 to potentiate cancer progression
Ashley N Pearson, Jessica Waninger, Amanda K Huber, et al.
Journal of Thrombosis and Haemostasis : JTH
|
August 1, 2019
Comparison of real world and core laboratory lupus anticoagulant results from the Antiphospholipid Syndrome Alliance for Clinical Trials and International Networking (APS ACTION) clinical database and repository
Maria Efthymiou, Ian J Mackie, Philip J Lane, et al.
Seminars in Arthritis and Rheumatism
|
June 3, 2019
The adjusted global antiphospholipid syndrome score (aGAPSS) and the risk of recurrent thrombosis: Results from the APS ACTION cohort
Massimo Radin, Savino Sciascia, Doruk Erkan, et al.
Nature Reviews. Cardiology
|
March 11, 2026
Antiphospholipid antibodies and cardiovascular thrombosis
Sina Rashedi, Hannah Leyva, Saman A Siddiqui, et al.
Arthritis Care & Research
|
February 3, 2025
Predictors of Mortality in Antiphospholipid Antibody-Positive Patients: Prospective Results From Antiphospholipid Syndrome Alliance for Clinical Trials and International Networking Clinical Database and Repository
Yasaman Ahmadzadeh, Larry S Magder, Danieli Castro Oliveira de Andrade, et al.
Advances in Rheumatology (London, England)
|
April 17, 2026
Do ethnoracial differences exist among antiphospholipid antibody-positive patients with no other systemic autoimmune diseases: results from the APS ACTION registry
Elena Gkrouzman, Alicia Matijasevich, Carolina Bonilla Richero, et al.
JCI Insight
|
April 1, 2025
Soluble CD13 is a potential mediator of neutrophil-induced thrombogenic inflammation in SARS-CoV-2 infection
Pei-Suen Tsou, Ramadan A Ali, Chenyang Lu, et al.
Cell Death and Differentiation
|
May 25, 2021
Patients with COVID-19: in the dark-NETs of neutrophils
Maximilian Ackermann, Hans-Joachim Anders, Rostyslav Bilyy, et al.
Cell Death and Differentiation
|
January 10, 2019
To NET or not to NET:current opinions and state of the science regarding the formation of neutrophil extracellular traps
Sebastian Boeltz, Poorya Amini, Hans-Joachim Anders, et al.
Arthritis & Rheumatology (Hoboken, N.J.)
|
August 28, 2023
The 2023 ACR/EULAR Antiphospholipid Syndrome Classification Criteria
Medha Barbhaiya, Stephane Zuily, Ray Naden, et al.
Page
of 17
Search research articles
Search
Showing results (151-160 of 161) with videos related to
Sort By:
Page
of 17
Cancer Immunology Research
|
September 4, 2025
Liver metastases license neutrophils through IL-1 to potentiate cancer progression
Ashley N Pearson, Jessica Waninger, Amanda K Huber, et al.
Journal of Thrombosis and Haemostasis : JTH
|
August 1, 2019
Comparison of real world and core laboratory lupus anticoagulant results from the Antiphospholipid Syndrome Alliance for Clinical Trials and International Networking (APS ACTION) clinical database and repository
Maria Efthymiou, Ian J Mackie, Philip J Lane, et al.
Seminars in Arthritis and Rheumatism
|
June 3, 2019
The adjusted global antiphospholipid syndrome score (aGAPSS) and the risk of recurrent thrombosis: Results from the APS ACTION cohort
Massimo Radin, Savino Sciascia, Doruk Erkan, et al.
Nature Reviews. Cardiology
|
March 11, 2026
Antiphospholipid antibodies and cardiovascular thrombosis
Sina Rashedi, Hannah Leyva, Saman A Siddiqui, et al.
Arthritis Care & Research
|
February 3, 2025
Predictors of Mortality in Antiphospholipid Antibody-Positive Patients: Prospective Results From Antiphospholipid Syndrome Alliance for Clinical Trials and International Networking Clinical Database and Repository
Yasaman Ahmadzadeh, Larry S Magder, Danieli Castro Oliveira de Andrade, et al.
Advances in Rheumatology (London, England)
|
April 17, 2026
Do ethnoracial differences exist among antiphospholipid antibody-positive patients with no other systemic autoimmune diseases: results from the APS ACTION registry
Elena Gkrouzman, Alicia Matijasevich, Carolina Bonilla Richero, et al.
JCI Insight
|
April 1, 2025
Soluble CD13 is a potential mediator of neutrophil-induced thrombogenic inflammation in SARS-CoV-2 infection
Pei-Suen Tsou, Ramadan A Ali, Chenyang Lu, et al.
Cell Death and Differentiation
|
May 25, 2021
Patients with COVID-19: in the dark-NETs of neutrophils
Maximilian Ackermann, Hans-Joachim Anders, Rostyslav Bilyy, et al.
Cell Death and Differentiation
|
January 10, 2019
To NET or not to NET:current opinions and state of the science regarding the formation of neutrophil extracellular traps
Sebastian Boeltz, Poorya Amini, Hans-Joachim Anders, et al.
Arthritis & Rheumatology (Hoboken, N.J.)
|
August 28, 2023
The 2023 ACR/EULAR Antiphospholipid Syndrome Classification Criteria
Medha Barbhaiya, Stephane Zuily, Ray Naden, et al.
Page
of 17